索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]关礼春,虞敏.贫血对心脏外科手术的影响及其铁缺乏机制[J].国际心血管病杂志,2017,04:210-214.
点击复制

贫血对心脏外科手术的影响及其铁缺乏机制(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2017年04期
页码:
210-214
栏目:
综述
出版日期:
2017-07-25

文章信息/Info

Title:
-
作者:
关礼春; 虞敏
200080 上海交通大学附属第一人民医院心脏及大血管外科
Author(s):
-
关键词:
贫血; 铁缺乏; 铁剂; 促红细胞生成素; 心脏外科手术
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2017.04.006
文献标识码:
-
摘要:
心脏外科手术患者常伴有贫血,贫血会增加术后死亡率和并发症发生率,并会延长住院时间。铁缺乏是贫血发生的重要原因,其主要存在形式是功能性铁缺乏。功能性铁缺乏的重要机制是慢性炎症引起铁调素升高,干扰了铁的吸收和利用。有研究尝试通过静脉补铁联合促红细胞生成素来改善心脏外科手术患者的贫血,但疗效尚有争议。
Abstract:
-

参考文献/References

[1] Musallam KM, Tamim HM, Richards T, et al. Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study[J]. Lancet, 2011, 378(9800):1396-1407.
[2] Hung M, Besser M, Sharples LD, et al. The prevalence and association with transfusion, intensive care unit stay and mortality of pre-operative anaemia in a cohort of cardiac surgery patients[J]. Anaesthesia, 2011, 66(9):812-818.
[3] Karkouti K, Wijeysundera DN, Beattie WS, et al. Risk associated with preoperative anemia in cardiac surgery: a multicenter cohort study[J]. Circulation, 2008, 117(4):478-484.
[4] Carrascal Y, Maroto L, Rey J, et al. Impact of preoperative anemia on cardiac surgery in octogenarians[J]. Interact Cardiovasc Thorac Surg, 2010, 10(2):249-255.
[5] van Straten AH, Hamad MA, van Zundert AJ, et al. Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting: a comparison with the matched general population[J]. Circulation, 2009, 120(2): 118-125.
[6] Kulier A, Levin J, Moser R, et al. Impact of preoperative anemia on outcome in patients undergoing coronary artery bypass graft surgery[J]. Circulation, 2007, 116(5):471-479.
[7] Zindrou D, Taylor KM, Bagger JP. Preoperative haemoglobin concentration and mortality rate after coronary artery bypass surgery[J]. Lancet, 2002, 359(9319):1747-1748.
[8] Boening A, Boedeker RH, Scheibelhut C, et al. Anemia before coronary artery bypass surgery as additional risk factor increases the perioperative risk[J]. Ann Thorac Surg, 2011, 92(3):805-810.
[9] Matsuda S, Fukui T, Shimizu J, et al. Associations between preoperative anemia and outcomes after off-pump coronary artery bypass grafting[J]. Ann Thorac Surg, 2013, 95(3):854-860.
[10] Surgenor SD, Kramer RS, Olmstead EM, et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery[J]. Anesth Analg, 2009, 108(6):1741-1746.
[11] Hajjar LA, Vincent JL, Galas FR, et al. Transfusion requirements after cardiac surgery: the TRACS randomized controlled trial[J]. JAMA, 2010, 304(14):1559-1567.
[12] Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery[J]. Circulation, 2007, 116(22):2544-2552.
[13] Cladellas M, Farré N, Comín-Colet J, et al. Effects of preoperative intravenous erythropoietin plus iron on outcome in anemic patients after cardiac valve replacement[J]. Am J Cardiol, 2012, 110(7):1021-1026.
[14] Ranucci M, Baryshnikova E, Castelvecchio S, et al. Major bleeding, transfusions, and anemia: the deadly triad of cardiac surgery[J]. Ann Thorac Surg, 2013, 96(2): 478-485.
[15] Ranucci M, Di Dedda U, Castelvecchio S, et al. Impact of preoperative anemia on outcome in adult cardiac surgery: a propensity-matched analysis[J]. Ann Thorac Surg, 2012, 94(4):1134-1142.
[16] De Santo L, Romano G, Della Corte A, et al. Preoperative anemia in patients undergoing coronary artery bypass grafting predicts acute kidney injury[J]. J Thorac Cardiovasc Surg, 2009, 138(4):965-970.
[17] London GM, Parfrey PS. Cardiac disease in chronic uremia: pathogenesis[J]. Adv Ren Replace Ther, 1997, 4(3):194-211.
[18] Silverberg DS, Wexler D, Iaina A. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?[J]. J Nephrol, 2004, 17(6):749-761.
[19] Guralnik JM, Eisenstaedt RS, Ferrucci L, et al. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia[J]. Blood, 2004, 104(8):2263-2268.
[20] Hung M, Ortmann E, Besser M, et al. A prospective observational cohort study to identify the causes of anaemia and association with outcome in cardiac surgical patients[J]. Heart, 2015, 101(2):107-112.
[21] Piednoir P, Allou N, Driss F, et al. Preoperative iron deficiency increases transfusion requirements and fatigue in cardiac surgery patients: a prospective observational study[J]. Eur J Anaesthesiol, 2011, 28(11):796-801.
[22] Theusinger OM, Leyvraz PF, Schanz U, et al. Treatment of iron deficiency anemia in orthopedic surgery with intravenous iron: efficacy and limits: a prospective study[J]. Anesthesiology, 2007, 107(6):923-927.
[23] Haas JD, Brownlie T. Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship[J]. J Nutr, 2001, 131(2S-2):676S-690S.
[24] Busti F, Campostrini N, Martinelli N. Iron deficiency in the elderly population, revisited in the hepcidin era[J]. Front Pharmacol, 2014, 5:83.
[25] Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency[J]. N Engl J Med, 2009, 361(25):2436-2448.
[26] Weiss G, Goodnough LT. Anemia of chronic disease[J]. N Engl J Med, 2005, 352(10):1011-1023.
[27] Suzuki T, Hanawa H, Ding L, et al. Improvement of anemia with decreasing hepcidin levels following valve replacement for severe tricuspid regurgitation[J]. Eur J Haematol, 2012, 88(6):551-552.
[28] Ganz T. Hepcidin and iron regulation, 10 years later[J]. Blood, 2011, 117(17):4425-4433.
[29] Karkouti K, Mccluskey SA, Ghannam M, et al. Intravenous iron and recombinant erythropoietin for the treatment of postoperative anemia[J]. Can J Anaesth, 2006, 53(1):11-19.
[30] Madi-Jebara SN, Sleilaty GS, Achouh PE, et al. Postoperative intravenous iron used alone or in combination with low-dose erythropoietin is not effective for correction of anemia after cardiac surgery[J]. J Cardiothorac Vasc Anesth, 2004, 18(1):59-63.
[31] Garrido-Martín P, Nassar-Mansur MI, de la Llana-Ducrós R, et al. The effect of intravenous and oral iron administration on perioperative anaemia and transfusion requirements in patients undergoing elective cardiac surgery: a randomized clinical trial[J]. Interact Cardiovasc Thorac Surg, 2012, 15(6):1013-1018.
[32] Cuenca J, García-Erce JA, Muñoz M, et al. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study[J]. Transfusion, 2004, 44(10):1447-1452.
[33] Cuenca J, García-Erce JA, Martínez AA, et al. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair: preliminary data[J]. Arch Orthop Trauma Surg, 2005, 125(5):342-347.
[34] Edwards TJ, Noble EJ, Durran A, et al. Randomized clinical trial of preoperative intravenous iron sucrose to reduce blood transfusion in anaemic patients after colorectal cancer surgery[J]. Br J Surg, 2009, 96(10):1122-1128.
[35] Avni T, Leibovici L, Gafter-Gvili A. Iron supplementation for the treatment of chronic heart failure and iron deficiency: systematic review and meta-analysis[J]. Eur J Heart Fail, 2012, 14(4):423-429.
[36] Vaislic CD, Dalibon N, Ponzio O, et al. Outcomes in cardiac surgery in 500 consecutive Jehovah's Witness patients: 21 year experience[J]. J Cardiothorac Surg, 2012, 7:95.

备注/Memo

备注/Memo:
基金项目:国家自然科学基金(81300094)
通信作者:虞 敏,Email:minyudr@163.com
更新日期/Last Update: 2017-07-25